Eran Ovadya, Chief Financial Officer of NurExone stated, “The ISCT 2025 conference is a key opportunity to showcase our advances and to expand our U.S. presence. As we grow Exo-Top and pursue U.S.
Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Toichi Takino; “Ono”) announced that the U.S. Food and Drug Administration (FDA) has approved ROMVIMZA™ (vimseltinib), a kinase ...
Aby J. Mathew, Executive Vice President and Chief Scientific Officer at BioLife Solutions Inc. (NASDAQ:BLFS), recently sold 92 shares of the company's common stock. The transaction, executed on ...
News 8 is once again honoring Black history by looking at health care and the racial disparities many report facing.
Karen A. Foster, the Chief Quality and Operations Officer at Biolife Solutions Inc. (NASDAQ:BLFS), recently sold a portion of her company stock. According to a Form 4 filing with the Securities and ...
American Society of Clinical Oncology Genitourinary (ASCO GU) cancers symposium held in San Francisco, CA between February 13 th and 15 th 2025, was host to the Panning for Gold: The Role of ctDNA as ...
The US Food and Drug Administration has approved vimseltinib (Romvimza, Deciphera Pharmaceuticals, LLC) to treat adult ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback